Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/26/2026, 3:49:09 PM
Content snapshot
{ "session_id": "hyp-debate-664901bf-05fc304fe0", "round_number": 2, "agent_persona": "persona-Skeptic", "agent_backend": "codex", "action": "critique", "content": "Skeptic critique of 'TLR4 priming is the actionable driver in: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration th':\nThe central weakness is causal ordering. The evidence bundle contains useful mechanistic and biomarker anchors, but most items are search-derived or inherited from a gap debate and therefore do not yet prove that TLR4 priming is upstream of neuronal injury in the relevant disease context.\n\nKey weaknesses:\n- causal direction requires longitudinal perturbation\n- evidence_validation_score is still unset, so citations need claim-level validation\n\nA decisive test needs cell-type-aware longitudinal sampling, perturbation in the predicted direction, and a negative-control pathway to rule out a generic stress response. Without those controls, the same observations could support compensation, disease severity tracking, or cohort-composition effects.", "hypotheses_referenced": "h-gap-2f2e5b80-m1", "evidence_cited": "[\"four_round_gap_debate [four_round_gap_debate]\", \"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. [33057840]\", \"The role of the microbiota in glaucoma. [37866106]\", \"The role of Toll-like receptors and neuroinflammation in Parkinson's disease. [35668422]\"]", "confidence": 0.743, "argument": "Skeptic critique of 'TLR4 priming is the actionable driver in: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration th':\nThe central weakness is causal ordering. The evidence bundle contains useful mechanistic and biomarker anchors, but most items are search-derived or inherited from a gap debate and therefore do not yet prove that TLR4 priming is upstream of neuronal injury in the relevant disease context.\n\nKey weaknesses:\n- causal direction requires longitudinal perturbation\n- evidence_validation_score is still unset, so citations need claim-level validation\n\nA decisive test needs cell-type-aware longitudinal sampling, perturbation in the predicted direction, and a negative-control pathway to rule out a generic stress response. Without those controls, the same observations could support compensation, disease severity tracking, or cohort-composition effects.", "evidence": "[\"four_round_gap_debate [four_round_gap_debate]\", \"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. [33057840]\", \"The role of the microbiota in glaucoma. [37866106]\", \"The role of Toll-like receptors and neuroinflammation in Parkinson's disease. [35668422]\"]" }